Since after HSCT, occurrence of GVHD depends on neovascularization and endothelial damage, increased markers of EC biology such as von Willebrand factor (vWF) and thrombomodulin in the peripheral blood can be useful in the diagnosis of GVHD [11]. This evidence concerns the gene THBD and graft versus host disease.